Finch Therapeutics Group, Inc.

FNCHQ

⚠ Showing the latest available close (Oct 1, 2026, 35 days ago). Our price provider hasn't published a newer EOD for this ticker yet. Price-dependent metrics (P/E, P/FCF, yield) may not reflect current market conditions.

We are a microbiome technology company with a portfolio of intellectual property and microbiome assets. Our objectives are to realize the value of our intellectual property estate through licensing our technology to collaboration partners and enforcing our patent rights against infringing parties through intellectual property litigation and, in certain cases, to generate additional data on sele…

Valuation & Multiples

Based on TTM earnings · Diluted shares

Market Cap$17M

EPS-$8.49

P/E-1.22

P/FCF-0.92

EV/EBITDA-1.52

FCF Yield–

Div. Yield–

Net Debt/FCF-0.7x

Finch Therapeutics Group, Inc. intrinsic value

52-Week Range

$6.21$14.56

Profitability & Returns

TTM as of 2024-06 · YoY vs prior year · ROIC = NOPAT / invested capital

Revenue (TTM)

$0.00

▼ -87.6% YoY

Net Income (TTM)

-$14M

▲ +34.8% YoY

Op. Margin

-78374.77%

▼ -64949.3pp YoY

ROIC

-30.60%

▼ -14.6pp YoY

Cash Flow & Balance Sheet

FCF = operating cash flow + capex · Net debt = total debt − cash · Balance sheet from latest filing

FCF (TTM)

-$18M

▲ +59.1% YoY

Op. Cash Flow (TTM)

-$18M

▲ +57.9% YoY

Net Debt

$13M

Cash & Equiv.

$16M

3Y CAGR: -76.0%

Continue Research

Quality Scorecard

Is this a high-quality business?

Dividends

Payout safety and growth

Intrinsic Value

What is it worth?

Financials

Full income, cash flow, balance sheet

Peers

Biological Products, (No Diagnostic Substances) · Pick stocks to compare with FNCHQ

CompareIntrinsic value

VIVSVivoSim Labs, Inc.

$0.15+8.71%10

IPSCCentury Therapeutics, Inc.

$1.67+9.87%40

STROSutro Biopharma, Inc.

$9.94+4.52%10

HUMAHumacyte, Inc.

$0.45+2.04%10

DYAIDyadic International Inc.

$0.37+1.86%36

TCRXTScan Therapeutics Inc.

$0.21+11.11%10

BCDABioCardia, Inc.

$0.91-0.75%20

PLXProtalix Biotherapeutics Inc.

$2.69+3.07%68

Finch Therapeutics Group (FNCHQ) in three numbers

Quality score: 0/100; Best check: margin trend, -77863.9pp.; Quality
Dividend: None; No dividend in the SEC filings we hold.; Dividends
P/E: -1.22; Negative: a loss over the last twelve months. Price to free cash flow -0.92.; Financials

Questions about Finch Therapeutics Group

Is Finch Therapeutics Group a high-quality business?

Finch Therapeutics Group scores 0 out of 100 on Intrinsiqq's quality score, which makes it a lower-quality business on these measures. The score blends 5 checks computed from SEC filings. Its best check is margin trend at -77863.9pp. The Quality tab shows every check against its target.

Does Finch Therapeutics Group (FNCHQ) pay a dividend?

No. Finch Therapeutics Group (FNCHQ) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.

Source: 10-Q filed 9 Aug 2024 (period ending 30 Jun 2024), SEC. Price: last close 1 Oct 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.

Spot a number that looks wrong? Check it in FNCHQ's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing FNCHQ

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.